CSIMarket
 

Cypherpunk Technologies Inc   (NASDAQ: CYPH)

Cypherpunk Technologies Inc 's

Competitiveness




 

CYPH Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Cypherpunk Technologies Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 8.31 %, recorded in the same quarter.

List of CYPH Competitors





Revenue Growth Comparisons




Net Income Comparison


Cypherpunk Technologies Inc , slower than the average decrease reported by the company's competitors of -77.26 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -77.26 %

<<  CYPH Stock Performance Comparisons


Cypherpunk Technologies Inc 's Comment on Competition and Industry Peers


The company competes with major pharmaceutical and biotechnology firms, academic institutions, governmental agencies, and public and private research organizations. Its product candidates face competition from existing and emerging therapies. Key competitive factors include efficacy, safety, convenience, ease of use, effectiveness of companion diagnostics, generic competition, and reimbursement availability from government and third-party payors. Competitors may also achieve regulatory approval more quickly, affecting the company's market position.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Cypherpunk Technologies Inc




Third Harmonic Bio Inc
Share Performance



-55.68%
One Year



Third Harmonic Bio Inc
Profile

Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.

More about Third Harmonic Bio Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 241.654 mill. $ - mill. $ 53.447 mill.


Amedisys Inc
Share Performance



0.00%
30 Days



Amedisys Inc
Profile

Amedisys Inc's business model is focused on providing home health, hospice, and personal care services to patients.

More about Amedisys Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,361.856 mill. $ 2,402.365 mill. $ 81.868 mill.


Adlai Nortye Ltd
Share Performance



+880.43%
This Year



Adlai Nortye Ltd
Profile

Adlai Nortye Ltd. is a holding company incorporated in the Cayman Islands, with subsidiaries operating in the United States and China.

More about Adlai Nortye Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,297.844 mill. $ 6.472 mill. $ -35.528 mill.


Actinium Pharmaceuticals Inc
Share Performance



-26.28%
This Year



Actinium Pharmaceuticals Inc
Profile

Actinium Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of targeted therapies for the treatment of various cancers.

More about Actinium Pharmaceuticals Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 31.721 mill. $ 35.090 mill. $ 37.853 mill.


Bolt Biotherapeutics Inc
Share Performance



-19.68%
One Year



Bolt Biotherapeutics Inc
Profile

Bolt Biotherapeutics Inc's business model focuses on developing novel immunotherapies for the treatment of cancer.

More about Bolt Biotherapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6.722 mill. $ 6.499 mill. $ -29.580 mill.

87 more competitors available

Sign in to see all competitors

Sources: Cypherpunk Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cypherpunk Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.